1
0
0
News
EMPA-Kidney: 'Empa'sizing the role of Flozins in Chronic ...NephJC
www.nephjc.com
— ... Jens Eilbracht , Martina Brueckmann , Martin J Landray, Colin Baigent, Richard Haynes. PMID: Also read: Meta-analysis of all major — ... Jens Eilbracht , Martina Brueckmann , Martin J Landray, Colin Baigent, Richard Haynes. PMID: Also read: Meta-analysis of all major ...
Interessen
Empagliflozin in Patients with Chronic Kidney DiseaseThe New England Journal of Medicine
www.nejm.org
— Tuttle, M.D., Dominik Steubl, M.D., Michaela Petrini, M.H.S., Dan Massey, M.Sc., Jens Eilbracht, Ph.D., Martina Brueckmann, M.D., Martin J — Tuttle, M.D., Dominik Steubl, M.D., Michaela Petrini, M.H.S., Dan Massey, M.Sc., Jens Eilbracht, Ph.D., Martina Brueckmann, M.D., Martin J ...
a randomised, double-blind, placebo-controlled, phase 3 trialThe Lancet
www.thelancet.com
Prof Michael Roden, MD, Prof Jianping Weng, MD, Jens Eilbracht, PhD, Bruno Delafont, MSc, Gabriel Kim, MD, Prof Hans J Woerle, MD, Uli C Broedl, MD. The ... Prof Michael Roden, MD, Prof Jianping Weng, MD, Jens Eilbracht, PhD, Bruno Delafont, MSc, Gabriel Kim, MD, Prof Hans J Woerle, MD, Uli C Broedl, MD. The ...
Bücher
Jens Eilbracht scite author profilescite.ai
scite.ai
Jens Eilbracht ; 669Citation Statements Received ; 125Citation Statements Given. Jens Eilbracht ; 669Citation Statements Received ; 125Citation Statements Given.
NO66 - ein neuartiges Zellkernprotein an zwei WirkortenGoogle Books
books.google.com
Title, NO66 - ein neuartiges Zellkernprotein an zwei Wirkorten: dem Nukleolus und einem speziellen Typ Chromatin. Author, Jens Eilbracht. Published, Title, NO66 - ein neuartiges Zellkernprotein an zwei Wirkorten: dem Nukleolus und einem speziellen Typ Chromatin. Author, Jens Eilbracht. Published,
Haneda Mの検索結果 - Bibgraph（ビブグラフ）| PubMedを ...Bibgraph
bibgraph.hpcr.jp
... Jens Eilbracht ,Martina Brueckmann ,Martin J Landray ,Colin Baigent ,Richard Haynes. The New England journal of medicine(N Engl J Med)2023Jan12. メジャー Jens Eilbracht ,Martina Brueckmann ,Martin J Landray ,Colin Baigent ,Richard Haynes. The New England journal of medicine(N Engl J Med)2023Jan12. メジャー ...
HEIDI: Eilbracht, Jens: NO66 - ein neuartiges Zellkernprotein an zwei...
katalog.ub.uni-heidelberg.de
Titel: NO66 - ein neuartiges Zellkernprotein an zwei Wirkorten: dem Nukleolus und einem speziellen Typ Chromatin. Verf.angabe: vorgelegt von Jens Eilbracht.
Dokumente zum Namen
Diabetes ClínicaANAD – Associação Nacional de Atenção ao Diabetes
www.anad.org.br
PIEBER, SUSANNE FAMULLA,. JENS EILBRACHT, JESSICA CESCUTTI, NIMA. SOLEYMANLOU, ODD ERIK JOHANSEN, HANS J. WOERLE, ULI C. BROEDL, STEFAN KASPERS, Graz,. Áustria ... PIEBER, SUSANNE FAMULLA,. JENS EILBRACHT, JESSICA CESCUTTI, NIMA. SOLEYMANLOU, ODD ERIK JOHANSEN, HANS J. WOERLE, ULI C. BROEDL, STEFAN KASPERS, Graz,. Áustria ...
Empa Kidney | PDFScribd
www.scribd.com
... Jens Eilbracht, Stefan Hantel, Mark based at the Clinical Trial Service Unit and Epidemiologial Stud- Hopley, Martin J. Landray† , Colin Baigent† , Richard Jens Eilbracht, Stefan Hantel, Mark based at the Clinical Trial Service Unit and Epidemiologial Stud- Hopley, Martin J. Landray† , Colin Baigent† , Richard ...
Empagliflozin in Patients with Chronic Kidney DiseaseStudocu
www.studocu.com
... Jens Eilbracht, Ph., Martina Brueckmann, M., Martin J. Landray, F.Med., Colin Baigent, F.Med., and Richard Haynes, D. The affiliations of the members of the Jens Eilbracht, Ph., Martina Brueckmann, M., Martin J. Landray, F.Med., Colin Baigent, F.Med., and Richard Haynes, D. The affiliations of the members of the ...
Traduzido Empagliflozin in Patients With Chronic ...Scribd
pt.scribd.com
... Jens Eilbracht, Ph.D., Martina Brueckmann, MD, Martin J. Landray, F.Med. Sci., Colin Baigent, F.Med.Sci., e Richard Haynes, DM As afiliações dos membros do Jens Eilbracht, Ph.D., Martina Brueckmann, MD, Martin J. Landray, F.Med. Sci., Colin Baigent, F.Med.Sci., e Richard Haynes, DM As afiliações dos membros do ...
Wissenschaftliche Veröffentlichungen
Empagliflozin monotherapy with sitagliptin as an active ...ScienceDirect.com
www.sciencedirect.com
von M Roden · · Zitiert von: 531 — ... MD a b * , Prof Jianping Weng MD c * , Jens Eilbracht PhD d , Bruno Delafont MSc e , Gabriel Kim MD f , Prof Hans J Woerle MD f , Uli C Broedl MD ... von M Roden · · Zitiert von: 531 — ... MD a b * , Prof Jianping Weng MD c * , Jens Eilbracht PhD d , Bruno Delafont MSc e , Gabriel Kim MD f , Prof Hans J Woerle MD f , Uli C Broedl MD ...
Identification of a sequence 4 protein to nuclear specklesJstor
www.jstor.org
Jens Eilbracht and Marion S. Schmidt-Zachmann*. Division of Cell Biology, German Cancer Research Center, Im Neuenheimer Feld 280,. Communicated by Joseph G ... Jens Eilbracht and Marion S. Schmidt-Zachmann*. Division of Cell Biology, German Cancer Research Center, Im Neuenheimer Feld 280,. Communicated by Joseph G ...
Vol 84, Issues 2–3, Pages (9 March 2005)ScienceDirect.com
www.sciencedirect.com
Jens Eilbracht, Sandra Kneissel, Astrid Hofmann, Marion S. Schmidt-Zachmann. Pages : View PDF. Article preview. select article Emerin expression in early ... Jens Eilbracht, Sandra Kneissel, Astrid Hofmann, Marion S. Schmidt-Zachmann. Pages : View PDF. Article preview. select article Emerin expression in early ...
Veröffentlichungen allgemein
Forschungsschwerpunkt Krebsentstehung und ...YUMPU
www.yumpu.com
— Christine Dreger ( ) Jens Eilbracht. Bettina Hämmerling (med.; ). Sandra Kneissel Alexandra König ( )
TRATAMIENTO DE LAS PERSONAS CON DIABETES ...Real Academia de Medicina y Cirugía de Sevilla
ramse.es
Pieber, Jens Eilbracht, Dietmar Neubacher, Nima. Soleymanlou, Hans J. Woerle, Uli C. Broedl, Stefan Kaspers “Glucose Exposure and. Variability with ... Pieber, Jens Eilbracht, Dietmar Neubacher, Nima. Soleymanlou, Hans J. Woerle, Uli C. Broedl, Stefan Kaspers “Glucose Exposure and. Variability with ...
Empagliflozin in Patients with Chronic Kidney Diseaserevistacientificafarma.com
revistacientificafarma.com
2023 · Zitiert von: 852 — Jens Eilbracht, Ph.D.,. Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population. Health, University of Oxford, UK · Zitiert von: 852 — Jens Eilbracht, Ph.D.,. Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population. Health, University of Oxford, UK ...
MDCK-MRP2 - Dkfz - YumpuYumpu
www.yumpu.com
Jens Eilbracht Stephanie Geiger ( ). Bettina Hämmerling (med.) Cathleen Hanisch ( ). Alexandra König Ute Patzelt (6/02-). › document › view › mdck-mr...
Sonstiges
Jens Eilbracht email address & phone number | Boehringer ...RocketReach
rocketreach.co
Jens Eilbracht, based in Germany, is currently a Clinical Development Operations Lead at Boehringer Ingelheim, bringing experience from previous roles at ... Jens Eilbracht, based in Germany, is currently a Clinical Development Operations Lead at Boehringer Ingelheim, bringing experience from previous roles at ...
Jens Eilbracht's research worksResearchGate
www.researchgate.net
Jens Eilbracht. ·. Sandra Kneissel. ·. Marion Schmidt-Zachmann ... Unrelated to phosphorylation but more structure/function based, the arginine/serine-rich ... Jens Eilbracht. ·. Sandra Kneissel. ·. Marion Schmidt-Zachmann ... Unrelated to phosphorylation but more structure/function based, the arginine/serine-rich ...
Jens Eilbracht - Media CentreEASD
www.easd.org
Jens Eilbracht. Send a message. INTERVIEWS. RESOURCES. Thomas Pieber. Show Co-Speakers. Empagliflozin reduces HbA1c with lower insulin doses in patients with ... Jens Eilbracht. Send a message. INTERVIEWS. RESOURCES. Thomas Pieber. Show Co-Speakers. Empagliflozin reduces HbA1c with lower insulin doses in patients with ...
"N Engl J Med"[journal] 检索结果 - 图书馆- 黑龙江中医药大学黑龙江中医药大学
lib.hljucm.net
;Jens Eilbracht.;Martina Brueckmann.;Martin J Landray.;Colin Baigent.;Richard Haynes. 来源: N Engl J Med 年388卷2期 页. 申请馆际互借; 第三方免费 ... ;Jens Eilbracht.;Martina Brueckmann.;Martin J Landray.;Colin Baigent.;Richard Haynes. 来源: N Engl J Med 年388卷2期 页. 申请馆际互借; 第三方免费 ...
Design, recruitment, and baseline characteristics of the ...Altmetric
www.altmetric.com
... Jens Eilbracht, Stefan Hantel, Mark Hopley, Martin J Landray, Colin Baigent, Richard Haynes, Colin Baigent, Martin J Landray, Christoph Wanner, William G Jens Eilbracht, Stefan Hantel, Mark Hopley, Martin J Landray, Colin Baigent, Richard Haynes, Colin Baigent, Martin J Landray, Christoph Wanner, William G ...
Design, recruitment, and baseline characteristics of the EMPA ...Oxford Academic
academic.oup.com
2022 · Zitiert von: 85 — ... Jens Eilbracht, Stefan Hantel, Mark Hopley, Martin J. Landray†, Colin Baigent†, Richard Haynes† (†denotes joint senior authors). Writing · Zitiert von: 85 — ... Jens Eilbracht, Stefan Hantel, Mark Hopley, Martin J. Landray†, Colin Baigent†, Richard Haynes† (†denotes joint senior authors). Writing ...
Design, recruitment, and baseline characteristics of the EMPA- ...Elsevier
providence.elsevierpure.com
... Jens Eilbracht, Stefan Hantel, Mark Hopley, Martin J. Landray, Colin Baigent, Richard Haynes, Colin Baigent, Martin J. Landray, Christoph Wanner, William G Jens Eilbracht, Stefan Hantel, Mark Hopley, Martin J. Landray, Colin Baigent, Richard Haynes, Colin Baigent, Martin J. Landray, Christoph Wanner, William G ...
Empagliflozin decreases glucose exposure and ...EASD
www.easd.org
Jens Eilbracht · Susanne Famulla · Dietmar Neubacher · Thomas Pieber · Nima Soleymanlou. Co-Authors: Contact & Follow. Write a comment. Send a message. Add ... Jens Eilbracht · Susanne Famulla · Dietmar Neubacher · Thomas Pieber · Nima Soleymanlou. Co-Authors: Contact & Follow. Write a comment. Send a message. Add ...
Empagliflozin in Patients with Chronic Kidney Disease - ICH GCPichgcp.net
ichgcp.net
... Jens Eilbracht, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes. Abstract. Background: The effects of empagliflozin in patients with Jens Eilbracht, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes. Abstract. Background: The effects of empagliflozin in patients with ...
Empagliflozin in Patients with Chronic Kidney Disease.Providence Digital Commons
digitalcommons.providence.org
... Jens Eilbracht · Martina Brueckmann · Martin J Landray · Colin Baigent · Richard Haynes · The EMPA-KIDNEY Collaborative Group. Document Type. Article Jens Eilbracht · Martina Brueckmann · Martin J Landray · Colin Baigent · Richard Haynes · The EMPA-KIDNEY Collaborative Group. Document Type. Article ...
Empagliflozin in Patients with Chronic Kidney DiseaseAltmetric
www.altmetric.com
... Jens Eilbracht, Martina Brueckmann, Martin J. Landray, Colin Baigent, Richard Haynes [show]. View on publisher site Alert me about new mentions. X Jens Eilbracht, Martina Brueckmann, Martin J. Landray, Colin Baigent, Richard Haynes [show]. View on publisher site Alert me about new mentions. X ...
Empagliflozin in Patients with Chronic Kidney DiseaseElsevier
providence.elsevierpure.com
von EMPA-KIDNEY Collaborative Group · · Zitiert von: 852 — ... Jens Eilbracht and Martina Brueckmann and Landray, {Martin J.} and Colin Baigent and Richard Haynes",. note = "Publisher Copyright: {\textcopyright} von EMPA-KIDNEY Collaborative Group · · Zitiert von: 852 — ... Jens Eilbracht and Martina Brueckmann and Landray, {Martin J.} and Colin Baigent and Richard Haynes",. note = "Publisher Copyright: {\textcopyright}
Empagliflozin in Patients with Chronic Kidney DiseaseUniversità Cattolica del Sacro Cuore
publires.unicatt.it
... Jens Eilbracht, Giuseppe Grandaliano, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes Show 20 more. Show less. Department of Medicine and Jens Eilbracht, Giuseppe Grandaliano, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes Show 20 more. Show less. Department of Medicine and ...
Empagliflozin monotherapy with sitagliptin as an active ...scite.ai
scite.ai
Michael Roden. ,. Jianping Weng. ,. Jens Eilbracht. et al. Help me understand this report. Search citation statements. Order By: Relevance. Paper Sections. Michael Roden. ,. Jianping Weng. ,. Jens Eilbracht. et al. Help me understand this report. Search citation statements. Order By: Relevance. Paper Sections.
Glucose Exposure and Variability with Empagliflozin as ...Mary Ann Liebert, Inc.
www.liebertpub.com
von S Famulla · · Zitiert von: 71 — Susanne Famulla, · Thomas R. Pieber, · Jens Eilbracht, · Dietmar Neubacher, · Nima Soleymanlou, · Hans J. Woerle, · Uli C. · Stefan Kaspers. von S Famulla · · Zitiert von: 71 — Susanne Famulla, · Thomas R. Pieber, · Jens Eilbracht, · Dietmar Neubacher, · Nima Soleymanlou, · Hans J. Woerle, · Uli C. · Stefan Kaspers.
IgA nephropathy: an overview of drug treatments in clinical ...AI Chat for scientific PDFs
typeset.io
Tuttle,Dominik Steubl,Michaela Petrini,Dan Massey,Jens Eilbracht,Martina Brueckmann,Martin J Landray,Colin Baigent,Richard Haynes +37 more Oct Tuttle,Dominik Steubl,Michaela Petrini,Dan Massey,Jens Eilbracht,Martina Brueckmann,Martin J Landray,Colin Baigent,Richard Haynes +37 more Oct
J. Eilbracht's research worksResearchGate
www.researchgate.net
56 Citations. Susanne Famulla. ·. Thomas R Pieber. ·. Jens Eilbracht. ·. [...] ·. Stefan Kaspers. Background: We evaluated the effect of empagliflozin as Citations. Susanne Famulla. ·. Thomas R Pieber. ·. Jens Eilbracht. ·. [...] ·. Stefan Kaspers. Background: We evaluated the effect of empagliflozin as ...
Kidney disease trials for the 21st centuryOUCI
ouci.dntb.gov.ua
... Jens Eilbracht, Stefan Hantel, Mark Hopley, Martin J Landray, Colin Baigent, Richard Haynes, Colin Baigent, Martin J Landray, Christoph Wanner, William G Jens Eilbracht, Stefan Hantel, Mark Hopley, Martin J Landray, Colin Baigent, Richard Haynes, Colin Baigent, Martin J Landray, Christoph Wanner, William G ...
NO66, a Highly Conserved Dual Location Protein in ...Molecular Biology of the Cell (MBoC)
www.molbiolcell.org
von J Eilbracht · · Zitiert von: 66 — Jens Eilbracht · Michaela Reichenzeller · Michaela Hergt · Martina Schnölzer · Hans Heid · Michael Stöhr · Werner W. Franke · Marion S. Schmidt-Zachmann. von J Eilbracht · · Zitiert von: 66 — Jens Eilbracht · Michaela Reichenzeller · Michaela Hergt · Martina Schnölzer · Hans Heid · Michael Stöhr · Werner W. Franke · Marion S. Schmidt-Zachmann.
NO66, a highly conserved dual location protein in the ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von J Eilbracht · · Zitiert von: 66 — Authors. Jens Eilbracht , Michaela Reichenzeller, Michaela Hergt, Martina Schnölzer, Hans Heid, Michael Stöhr, Werner W Franke, Marion S Schmidt-Zachmann ... von J Eilbracht · · Zitiert von: 66 — Authors. Jens Eilbracht , Michaela Reichenzeller, Michaela Hergt, Martina Schnölzer, Hans Heid, Michael Stöhr, Werner W Franke, Marion S Schmidt-Zachmann ...
sortiert nach Relevanz / Datum